Safety and Antiviral Activity of Tmc435350 in Treatment-name Genotype 1 Hcv-infected Patients

Michael P. Manns; Yves Horsmans; Hendrik W. Reesink; Christophe Moreno; Thomas Berg; Yves Benhamou; Geoffrey Dusheiko; Robert Flisiak; Paul Meyvisch; Oliver Lenz

doi:10.1002/hep.22502

Safety and Antiviral Activity of Tmc435350 in Treatment-name Genotype 1 Hcv-infected Patients

Identifier:nobleid.org/w1/20260515/1FF2DB2A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1FF2DB2A.svg?ark=w1%2F20260515%2F1FF2DB2A)](https://nobleid.org/work/w1/20260515/1FF2DB2A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Safety and Antiviral Activity of Tmc435350 in Treatment-name Genotype 1 Hcv-infected Patients

Identifier:nobleid.org/w1/20260515/1FF2DB2A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1FF2DB2A.svg?ark=w1%2F20260515%2F1FF2DB2A)](https://nobleid.org/work/w1/20260515/1FF2DB2A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work